University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 2 of 23
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)
NCT06636786
Stress Trajectories and Anhedonia in Adolescence Research Study
NCT07040449
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
NCT06724406
Improving Appetite Self-Regulation in African American Adults With Type 2 Diabetes
NCT05741125
Treating Binge Eating and Obesity Digitally in Black Women
NCT05693896
Physical Activity and Community EmPOWERment Project
NCT06740162
Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations
NCT06735976
Resilience Through Interventions for Successful Early Outcomes
NCT06669624
Graded Exposure and Mindfulness Meditation for Patients Post-ACL Reconstruction
NCT05949177
Eating Disorders Genetics Initiative 2
NCT06594913
Hypertonic Saline in NCFB
NCT06242795
Teachers Leading the Front Lines - North Carolina (Tealeaf-NC)
NCT06587230
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART
NCT06405373
Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression
NCT06610305
Promoting Improved Functioning Among People Experiencing Stressful Situations
NCT06482567
Dose Optimization of Caffeine for HIE
NCT06448780
Flexibility, Alcohol Misuse, and Excitation
NCT06634771
Rifaximin for the Secondary Prevention of Recurrent Pouchitis
NCT06312683
Effects of "Alliance180 Program" on Well-Being
NCT06451523
A Pragmatic Rehabilitation Intervention: The Active Rehab Study
NCT05320822
Beta-Blocker Influences on Inflammatory and Neural Responses to Stress
NCT06263452
Apathy in Parkinson Disease TMS Study
NCT06087926
Ultrasound for Evaluation of Percutaneous G-tube Position
NCT06361498
The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
NCT06059664
Psilocybin-Assisted Therapy in Treatment-Resistant Depression
NCT06303739
Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults
NCT06044571
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
NCT06239688
Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery
NCT06179004
3-D Tractography FUS Ablation for Essential Tremor
NCT06331052
Adverse Adolescent Pathways to Substance Use
NCT06977178
Avocado Consumption, Nutrients in Human Milk, and Infant Cognitive Development
NCT06208085
Feasibility Test of Action Planning in Pediatric IBD
NCT06186752
Comparing Cognitive-Behavioral Therapy Versus Mindfulness-Based Therapy for Autistic Adults
NCT06060860
The Validation Study of Bioelectronics
NCT05397951
Fit for Duty: mHealth Intervention for Weight Gain Prevention
NCT06110273
Precision Medicine and Physical Function
NCT05877846
GI Alpha-Gal Study
NCT06268717
Education and Employment Support for HIV Prevention in Young Adults (ENSPIRE)
NCT06096324
Virtual Reality Mindfulness Meditation After ACL Reconstruction
NCT05527171
Adolescent Mood During Puberty and Testosterone
NCT06072677
Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease
NCT05864157
Cochlear Implants in Young Children With SSD
NCT05775367
Gait Rehabilitation to Treat FastOA
NCT05848622
Accountability for Care Through Undoing Racism & Equity for Moms
NCT05484804
Animal Assisted Therapy in Pediatric Dentistry
NCT05464888
Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI
NCT05480995
Depression, Aging, Stress and Heart Health Study
NCT05570721
Sitting Interruption and Whole-body Cardiovascular Health
NCT05316571
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
NCT05233150
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
NCT05282277
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets.Report a data error.